These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10502041)

  • 1. Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors.
    Frankel B; Longo SL; Ryken TC
    Acta Neuropathol; 1999 Oct; 98(4):363-6. PubMed ID: 10502041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2.
    Frankel B; Longo SL; Ryken TC
    J Neurooncol; 1999; 44(3):205-12. PubMed ID: 10720200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas.
    Strege RJ; Godt C; Stark AM; Hugo HH; Mehdorn HM
    J Neurooncol; 2004; 67(1-2):29-39. PubMed ID: 15072445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors.
    Fujita H; Koji T; Kitagawa N; Tsutsumi K; Abe K; Kaminogo M; Shibata S
    Cell Mol Neurobiol; 2002 Aug; 22(4):393-406. PubMed ID: 12507389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.
    Husain N; Chiocca EA; Rainov N; Louis DN; Zervas NT
    Acta Neuropathol; 1998 Mar; 95(3):287-90. PubMed ID: 9542594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.
    Gratas C; Tohma Y; Van Meir EG; Klein M; Tenan M; Ishii N; Tachibana O; Kleihues P; Ohgaki H
    Brain Pathol; 1997 Jul; 7(3):863-9. PubMed ID: 9217971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.
    Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I
    Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
    Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
    Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions.
    Fernández-Figueras MT; Armengol P; Puig L; Molinero JL; Esquius M; Sirera G; Ariza A
    J Cutan Pathol; 1999 Oct; 26(9):417-23. PubMed ID: 10563496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
    Rajashekhar G; Loganath A; Roy AC; Mongelli JM
    Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in cultured rat islets of langerhans and occurrence of Bcl-2, Bak, Bax, Fas and Fas ligand.
    Hanke J
    Cells Tissues Organs; 2001; 169(2):113-24. PubMed ID: 11399851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
    Tani E; Kitagawa H; Ikemoto H; Matsumoto T
    FEBS Lett; 2001 Aug; 504(1-2):53-8. PubMed ID: 11522296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effect of xinfeng capsule in treating adjuvant arthritis in rats and its effect on fas, fasL and bcl-2 expression in synovial membrane].
    Liu J; Zhang WD; Chen GL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Aug; 22(8):599-602. PubMed ID: 12572382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.